Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Choroidal Neovascularization”

339 trials

Showing 20 of 339 results

Large-scale testing (Phase 3)Study completedNCT01716026
What this trial is testing

Initial Treatment With Bevacizumab in Choroidal Neovascularization Associated to High Myopia

Who this might be right for
Choroidal Subfoveal/Juxtafoveal Neovascularization in High Myopia
Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA 66
Early research (Phase 1)Study completedNCT01835015
What this trial is testing

Pharmacokinetics of CLG561 in Patients With Advanced Age-Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Alcon Research 50
Not applicableStudy completedNCT01010997
What this trial is testing

Foresee Home for Monitoring Age Related Macular Degeneration (AMD)

Who this might be right for
Age Related Macular Degeneration
Notal Vision Ltd. 10
Not applicableStudy completedNCT00359008
What this trial is testing

PHP Home Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization (CNV)

Who this might be right for
Age Related Macular Degeneration
Notal Vision Ltd. 336
Not applicableStudy completedNCT00088192
What this trial is testing

Intravitreous Pegaptanib Sodium Injection in Patients With Exudative Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Eyetech Pharmaceuticals
Testing effectiveness (Phase 2)Ended earlyNCT01021956
What this trial is testing

Safety and Preliminary Efficacy Study of WST11 (Stakel®)-Mediated VTP Therapy in Subjects With CNV Associated With AMD

Who this might be right for
Macular DegenerationChoroidal Neovascularization
Steba Biotech S.A. 10
Testing effectiveness (Phase 2)Ended earlyNCT02387957
What this trial is testing

A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)

Who this might be right for
Age-Related Macular Degeneration
Ophthotech Corporation 63
Testing effectiveness (Phase 2)WithdrawnNCT01015495
What this trial is testing

Ranibizumab Therapy for Choroidal Neovascularization (CNV) Asociated With Angioid Streaks

Who this might be right for
Angioid Streaks
University of Illinois at Chicago
Not applicableStudy completedNCT01256632
What this trial is testing

Evaluation of the Effect of Vitreous Composition Determined by Ultrasound and Optical Coherence Tomography (OCT) on Ranibizumab Therapy

Who this might be right for
Choroidal Neovascularization
Vision Research Foundation 40
Large-scale testing (Phase 3)Study completedNCT01249664
What this trial is testing

VEGF Trap-Eye in Choroidal Neovascularization Secondary to Pathologic Myopia (mCNV)

Who this might be right for
Myopia, Pathological
Bayer 122
Not applicableStudy completedNCT03941587
What this trial is testing

Comparing Intravitreal Aflibercept Monotherapy vs Aflibercept Combined With Reduced Fluence PDT in PCV Treatment

Who this might be right for
Polypoidal Choroidal Vasculopathy
Singapore National Eye Centre 60
Not applicableStudy completedNCT02287298
What this trial is testing

Triple Combination Therapy of Choroidal Neovascularization in AMD, a Cost Effect and Efficient Therapeutic Treatment

Who this might be right for
Exudative Macular Degeneration
The Retina Center of St. Louis County, PC 400
Early research (Phase 1)Temporarily pausedNCT04222842
What this trial is testing

CM082 in Patients With Myopic Choroidal Neovascularization (CNV)

Who this might be right for
Myopic Choroidal Neovascularisation
AnewPharma 96
Testing effectiveness (Phase 2)Study completedNCT01242254
What this trial is testing

A Study Assessing the Safety and Efficacy of Multiple Intravitreal KH902 in Patients With CNV Due to AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Chengdu Kanghong Biotech Co., Ltd. 36
Not applicableLooking for participantsNCT07255859
What this trial is testing

CRYSTALSIGHT Cohort 2.0

Who this might be right for
Maculopathy
Tan Tock Seng Hospital 60
Not applicableUnknownNCT03838679
What this trial is testing

Imaging of the Angiofibrotic Switch in Neovascular AMD

Who this might be right for
Age-related Macular DegenerationChoroidal Neovascularization
Medical University of Vienna 120
Not applicableNot Yet RecruitingNCT06243406
What this trial is testing

Study on the Biomarkers of Anti-VEGF Treatment for Choroidal Neovascularization

Who this might be right for
Choroidal Neovascularization
Beijing Hospital 80
Testing effectiveness (Phase 2)UnknownNCT04504123
What this trial is testing

MMP-9 Inhibition for Recalcitrant Wet AMD

Who this might be right for
Exudative Macular DegenerationWet Age-related Macular Degeneration
University of Iowa 50
Not applicableStudy completedNCT00417846
What this trial is testing

Age-related Macular Degeneration: Detection of Onset of New Choroidal Neovascularization (AMD DOC Study)

Who this might be right for
Maculopathy, Age-RelatedChoroidal Neovascularization
Johns Hopkins University 98
Large-scale testing (Phase 3)Study completedNCT00150202
What this trial is testing

Clinical Study Of EYE001 For Wet-Type AMD (Age-Related Macular Degeneration)

Who this might be right for
Macular Degeneration
Pfizer 90
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation